Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies

 Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies

Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies

Shots:

  • Tyris to receive up front, research milestone along with research funding and will be responsible for generating clinical lead candidates and will further progress them to clinical development
  • Almirall to get an exclusive option to acquire gene therapies and progress them through clinical development to commercialization
  • The collaboration will integrate Tyris’s non-viral based gene therapy technology and Almirall’s expertise in medical dermatology. The alliance will focus on developing next-generation gene therapies with transformational potential for rare genetic dermatology diseases

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Nature

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post